WAT heads into the back half of the week fundamentally reset: a sharp earnings beat on May 5th sent the stock up nearly 14% over the week to $342.75, shaking out short sellers and flipping options sentiment sharply bullish in a single session.
The Q1 print was the catalyst. Waters beat consensus EPS estimates by $0.39, with headlines pointing to acquisition integration gains from the Becton Dickinson biosciences deal. That $18.8 billion deal, completed in early 2026, transformed Waters from a pure instruments business into a broader life sciences platform — and Q1 appears to have been the first clean validation that the integration is delivering. Revenue and earnings both came in ahead of expectations, and the company issued Q2 2026 guidance, signalling confidence in the forward trajectory.
Shorts felt the move. Short interest entered the week at around 6.1% of free float — a moderately elevated level for a name this size — but the earnings gap clearly forced some covering. The week-on-week short position fell approximately 6.5%, bringing shares short to roughly 3.64 million. That decline was orderly rather than violent: the borrow market stayed untroubled throughout. Cost to borrow ran at just 0.39% APR, down nearly 24% on the week and near its lowest levels in six months. Availability in the lending pool remains relaxed, with no signs of tightening pressure that would suggest squeeze mechanics at work. The short score — currently at 37.4 — has been drifting lower all week from a peak near 39.8 seen on April 27th, reinforcing that directional short pressure is fading rather than building.
Options traders moved decisively. The put/call ratio collapsed to 0.85 on May 5th, almost three standard deviations below its 20-day mean of 0.97. That is the most bullish options read in months; before this week, the ratio had been grinding between 0.94 and 1.05 for weeks, reflecting a market with little conviction either way. The sharp unwind of defensive positioning after the print suggests traders who had been hedging into the event quickly reversed.
The Street's reaction was prompt but restrained. JP Morgan raised its price target from $330 to $345 — keeping a Neutral rating — while TD Cowen moved its target to $385 from $345, also maintaining Hold. Both firms lifted targets the day after the print, acknowledging the beat but stopping short of ratings upgrades. The consensus target sits near $396, which is roughly 15% above the current price after the post-earnings gap. Earlier in the year, targets ran materially higher: Morgan Stanley had been as lofty as $423 before cutting to $350 in February, and B of A sliced from $410 to $350 after Q4 results. The net picture is a Street that has been anchoring lower over the first quarter, then catching up post-print but not yet rushing back to prior high-water marks. EPS momentum factor scores of 62 (30-day) and 60 (90-day) sit comfortably in the upper half of the universe, and the 12-month forward EPS year-on-year increase ranks in the 86th percentile — a genuinely strong forward earnings setup.
Institutional ownership gives additional texture. BlackRock added over 2.2 million shares as of end-April, lifting its stake to nearly 7.8% of shares outstanding. That is a notable incremental commitment heading into the print. Vanguard and State Street both added shares through March, adding passive flow support. On the insider side, the picture is mixed in timing rather than direction: the CEO and CFO both sold shares at $307 in early March — well below the current price — while two independent directors bought through mid-March near $289–$306. Those director purchases at lower levels now look well-timed, though the overall 90-day net insider activity skews to modest net selling given the CEO's $1.05 million transaction.
The next confirmed earnings event is scheduled for May 21st. With the stock gapping 14% higher in a week, the key question heading into that date is whether the integration narrative continues to track ahead of expectations — or whether the Q1 beat simply pulled forward enthusiasm that the next print will have to match.
See the live data behind this article on ORTEX.
Open WAT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
